🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial investigates the effect of nivolumab and ipilimumab whe...
Status
Active Not Recruiting
Location
Mobile Infirmary Medical Center
Start Date
2022-02-08
Trial ID
NCT04751370
This phase II trial studies how well nivolumab alone or in combination with...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2015-05-19
Trial ID
NCT02428192
Treatments Being Tested
This phase Ib trial studies the side effects of nivolumab and to see how we...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-16
Trial ID
NCT03816345
This randomized phase I trial studies the side effects and best way to give...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2013-08-28
Trial ID
NCT01940809
Treatments Being Tested
This phase I/Ib trial evaluates the best dose and side effects of ipilimuma...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-07-14
Trial ID
NCT04781855
Treatments Being Tested
This phase II trial studies how well ipilimumab with or without nivolumab w...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2017-10-23
Trial ID
NCT03033576
Treatments Being Tested
This phase I trial identifies the best dose of ipilimumab that can be admin...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2021-09-16
Trial ID
NCT04967196
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of ipilimumab ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2013-05-16
Trial ID
NCT01822509
Treatments Being Tested
This phase II trial studies how well cabozantinib works in combination with...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-05-13
Trial ID
NCT03866382
This phase III trial compares the usual treatment (treatment with ipilimuma...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2019-06-07
Trial ID
NCT03793166